share_log

Pasithea Therapeutics | 424B3: Prospectus

SEC ·  Apr 19, 2022 04:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more